Related references
Note: Only part of the references are listed.The evolution paths of some reprehensive scaffolds of RORγt modulators, a perspective from medicinal chemistry
Zhuohao Li et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2022)
Orthosteric and Allosteric Dual Targeting of the Nuclear Receptor RORγt with a Bitopic Ligand
Femke A. Meijer et al.
ACS CHEMICAL BIOLOGY (2021)
Cooperativity between the orthosteric and allosteric ligand binding sites of RORγt
Rens M. J. M. de Vries et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
Structure-Activity Relationship Studies of Trisubstituted Isoxazoles as Selective Allosteric Ligands for the Retinoic-Acid-Receptor-Related Orphan Receptor γt
Femke A. Meijer et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Agonist Lock Touched and Untouched Retinoic Acid Receptor-Related Orphan Receptor-γt (RORγt) Inverse Agonists: Classification Based on the Molecular Mechanisms of Action
Nannan Sun et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
A novel series of cysteine-dependent, allosteric inverse agonists of the nuclear receptor RORγt
Xin Jiang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2020)
Elucidation of an Allosteric Mode of Action for a Thienopyrazole RORγt Inverse Agonist
Rens M. J. M. de Vries et al.
CHEMMEDCHEM (2020)
Ligand-Based Design of Allosteric Retinoic Acid Receptor-Related Orphan Receptor γt (RORγt) Inverse Agonists
Femke A. Meijer et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Discovery of N-(Indazol-3-yl)piperidine-4-carboxylic Acids as RORγt Allosteric Inhibitors for Autoimmune Diseases
Hongjun Zhang et al.
ACS MEDICINAL CHEMISTRY LETTERS (2020)
Delineation of the molecular determinants of the unique allosteric binding site of the orphan nuclear receptor ROR?t
Iris A. Leijten-van de Gevel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2020)
RORγ Structural Plasticity and Druggability
Mian Huang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Allosteric small molecule modulators of nuclear receptors
Femke A. Meijer et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2019)
Molecular dynamics simulations on RORγt: insights into its functional agonism and inverse agonism
Cong-min Yuan et al.
ACTA PHARMACOLOGICA SINICA (2019)
Discovery and pharmacological evaluation of indole derivatives as potent and selective ROR gamma t inverse agonist for multiple autoimmune conditions
Nadim S. Shaikh et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2019)
Retinoic acid receptor-related orphan receptor gamma-t (RORγt) inhibitors in clinical development for the treatment of autoimmune diseases: a patent review (2016-present)
Nannan Sun et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2019)
Combating Autoimmune Diseases With Retinoic Acid Receptor-Related Orphan Receptor-γ (RORγ or RORc) Inhibitors: Hits and Misses
Vrajesh B. Pandya et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Molecular Mechanism of Action of RORt Agonists and Inverse Agonists: Insights from Molecular Dynamics Simulation
Nannan Sun et al.
MOLECULES (2018)
RORγ antagonists and inverse agonists: a patent review
Sarah M. Bronner et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2017)
A comprehensive map of molecular drug targets
Rita Santos et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
Structural studies unravel the active conformation of apo RORγt nuclear receptor and a common inverse agonism of two diverse classes of RORγt inhibitors
Xiang Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
NanoLuc Complementation Reporter Optimized for Accurate Measurement of Protein Interactions in Cells
Andrew S. Dixon et al.
ACS CHEMICAL BIOLOGY (2016)
Recent progress on nuclear receptor RORγ modulators
Patrick Cyr et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
Discovery of phenoxyindazoles and phenylthioindazoles as RORγ inverse agonists
Gilles Ouvry et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
Structural determinant for inducing RORgamma specific inverse agonism triggered by a synthetic benzoxazinone ligand
Douglas J. Marcotte et al.
BMC STRUCTURAL BIOLOGY (2016)
Family reunion of nuclear hormone receptors: structures, diseases, and drug discovery
H. Eric Xu
ACTA PHARMACOLOGICA SINICA (2015)
Discovery of imidazo[1,5-a]pyridines and -pyrimidines as potent and selective RORc inverse agonists
Benjamin P. Fauber et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2015)
Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials
Christopher E. M. Griffiths et al.
LANCET (2015)
Identification of an allosteric binding site for RORγt inhibition
Marcel Scheepstra et al.
NATURE COMMUNICATIONS (2015)
Dimethyl fumarate in the treatment of relapsing-remitting multiple sclerosis: an overview
Roberto Bomprezzi
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2015)
ROR nuclear receptors: structures, related diseases, and drug discovery
Yan Zhang et al.
ACTA PHARMACOLOGICA SINICA (2015)
Reduction in lipophilicity improved the solubility, plasma-protein binding, and permeability of tertiary sulfonamide RORc inverse agonists
Benjamin P. Fauber et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2014)
Modulators of the Nuclear Receptor Retinoic Acid Receptor-Related Orphan Receptor-γ (RORγ or RORc)
Benjamin P. Fauber et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Harnessing Allostery: A Novel Approach to Drug Discovery
Shaoyong Lu et al.
MEDICINAL RESEARCH REVIEWS (2014)
Secukinumab in Plaque Psoriasis - Results of Two Phase 3 Trials
Richard G. Langley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Discovery of Tertiary Amine and Indole Derivatives as Potent RORγt Inverse Agonists
Ting Yang et al.
ACS MEDICINAL CHEMISTRY LETTERS (2014)
Allostery in Disease and in Drug Discovery
Ruth Nussinov et al.
CELL (2013)
Targeting Orphan Nuclear Receptors for Treatment of Metabolic Diseases and Autoimmunity
Thomas P. Burris et al.
CHEMISTRY & BIOLOGY (2012)
Structural Basis for Hydroxycholesterols as Natural Ligands of Orphan Nuclear Receptor RORγ
Lihua Jin et al.
MOLECULAR ENDOCRINOLOGY (2010)
T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma
Xuexian O. Yang et al.
IMMUNITY (2008)
The differentiation of human TH-17 cells requires transforming growth factor-β and induction of the nuclear receptor RORγt
Nicolas Manel et al.
NATURE IMMUNOLOGY (2008)
The orphan nuclear receptor RORγt directs the differentiation program of proinflammatory IL-17+ T helper cells
Ivaylo I. Ivanov et al.
CELL (2006)
The nuclear receptor superfamily
M Robinson-Rechavi et al.
JOURNAL OF CELL SCIENCE (2003)
Share Paper
